We put together this list of highlights from 2021! These are some of the people, the work, and the campaigns that made this HER’s best year yet! We are making Hyperemesis Gravidarum (HG) progress!
Read MoreHER Board members, Marlena Fejzo, PhD, and Patrick Mullen, MD, are running the first study of GDF15 in HG patients in the United States.
Read MoreMarlena Fejzo, PhD, HER Board Member and Research Advisor, presents at the American Society of Human Genetics Annual Meeting on the genetics of Hyperemesis Gravidarum (HG).
Read MoreRead the latest research on the safety of ondansetron (Zofran) in an HG pregnancy.
Read MoreDozens of mothers bravely raised their voices about the obstacles that prohibited them from being healthy, productive employees during their pregnancies, including insufficient job security and a lack of compassion from employers. We compiled their responses to make a succinct list employers can refer to when attempting to support employees with HG or other high risk pregnancy complications.
Read MoreDr. Marlena Fejzo, a geneticist at the University of Southern California and a HER Foundation Board of Directors, presented at the Fetal Medicine Foundation (FMF) about Hyperemesis Gravidarum (HG), its potential causes, and treatment options. Over 5600 medical professionals heard her speak, and the talk is freely available on the FMF’s website in English, Spanish, Russian, and Portuguese.
Read MoreThe HER Foundation publishes a new study demonstrating the effectiveness of the HyperEmesis Level Prediction (HELP) Score in identifying pregnant women with severe symptoms of NVP.
Read MoreSupport another 20 years of helping mothers and babies thrive. HER is the global voice and leader for HG research and education.
Read More- « Previous
- 1
- 2
- 3
- Next »